Agenus upgraded by H.C. Wainwright with a new price target
$AGEN
Biotechnology: Biological Products (No Diagnostic Substances)
Health Care
H.C. Wainwright upgraded Agenus from Neutral to Buy and set a new price target of $25.00
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 6/4/2025 | $25.00 | Neutral → Buy | H.C. Wainwright |
| 7/19/2024 | $35.00 → $8.00 | Outperform → Neutral | Robert W. Baird |
| 7/18/2024 | Outperform → Mkt Perform | William Blair | |
| 7/18/2024 | $9.00 | Buy → Neutral | H.C. Wainwright |
| 6/6/2023 | $8.00 | Outperform | Robert W. Baird |
| 6/6/2023 | $60.00 → $80.00 | Outperform | Robert W. Baird |
| 2/28/2023 | $8.00 | Buy | H.C. Wainwright |
| 9/28/2022 | $5.00 | Outperform | SMBC Nikko |
8-K - AGENUS INC (0001098972) (Filer)
DEFR14A - AGENUS INC (0001098972) (Filer)
8-K - AGENUS INC (0001098972) (Filer)